VA-006 Vaccinia Vaccine (ACAM2000) for the Production of VIGIV
Study sponsor: Emergent BioSolutions
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2012-02-14Actual
Enrollment · participants25Actual
Source updated2024-03-18Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.